Description
LL-37 (CAP-18) research peptide
LL-37 is the only human cathelicidin antimicrobial peptide, a 37-amino-acid cationic peptide cleaved from the hCAP-18 precursor. It is a key molecule in innate-immunity research.
Product details
| Compound | LL-37 (CAP-18 derived) |
|---|---|
| Class | Human cathelicidin antimicrobial peptide (37 amino acids) |
| Strength | 5mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What research has examined
- Antimicrobial activity: membrane disruption of bacteria in vitro.
- Immunomodulation: chemotaxis and cytokine signalling.
- Biofilm research: activity against bacterial biofilms.
Research interest does not establish a proven effect in humans.
Regulatory status
This compound is not an approved medicine. It is supplied only as a research chemical for laboratory use.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Protirelin (TRH Thyrotropin) · PAL-GHK · Mazdutide · All unreconstituted peptides
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.